Showing results (111-120 of 132) with videos related to

Sort By:
Pageof 14
Infectious Agents and Cancer|February 14, 2023
Prophylactic treatment with oral azithromycin in cancer patients during the COVID-19 pandemic (OnCoVID): a randomized, single-blinded, placebo-controlled phase 2 trialMaximilian J Mair, Agnieszka Maj-Hes, Alina Nussbaumer-Pröll, et al.
Frontiers in Immunology|May 8, 2024
A retrospective multicenter study on clinical and serological parameters in patients with MuSK myasthenia gravis with and without general immunosuppressionInga Koneczny, Marina Mané-Damas, Shenghua Zong, et al.
Frontiers in Immunology|October 17, 2025
Severe COVID-19 induces prolonged elevation of the acute-phase protein pentraxin 3Bernhard Kratzer, Robert B Stieger, Seyma Durmus, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 20, 2026
GDF-15 Levels in Cirrhosis Are Linked to Hepatic Fibrogenesis, Bacterial Translocation, and Worse Clinical OutcomesBenedikt Silvester Hofer, Thomas Perkmann, Ksenia Brusilovskaya, et al.
Allergy|October 31, 2020
Immunological imprint of COVID-19 on human peripheral blood leukocyte populationsBernhard Kratzer, Doris Trapin, Paul Ettel, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 25, 2014
Additive gene-environment effects on hippocampal structure in healthy humansUlrich Rabl, Bernhard M Meyer, Kersten Diers, et al.
Annals of the Rheumatic Diseases|August 17, 2022
Immunogenicity and safety of a fourth COVID-19 vaccination in rituximab-treated patients: an open-label extension studyDaniel Mrak, Elisabeth Simader, Daniela Sieghart, et al.
Journal of the American Society of Nephrology : JASN|January 14, 2021
A Randomized Clinical Trial of Anti-IL-6 Antibody Clazakizumab in Late Antibody-Mediated Kidney Transplant RejectionKonstantin Doberer, Michael Duerr, Philip F Halloran, et al.
The Journal of Allergy and Clinical Immunology|August 3, 2023
Nasal IL-13 production identifies patients with late-phase allergic responsesNicholas J Campion, Sergio Villazala-Merino, Ryan S Thwaites, et al.
Annals of the Rheumatic Diseases|January 14, 2022
Additional heterologous versus homologous booster vaccination in immunosuppressed patients without SARS-CoV-2 antibody seroconversion after primary mRNA vaccination: a randomised controlled trialMichael Bonelli, Daniel Mrak, Selma Tobudic, et al.
Pageof 14